Date | Time | Place | Session / Title | Role |
April 25 | 6:00 PM - 8:00 PM | Presentation Theater, Level 1 | HKSTENT @ TCTAP 2017: Deep Dive Session on Left Main Intervention 2017 | Moderator |
April 25 | 6:13 PM - 6:28 PM | Presentation Theater, Level 1 | HKSTENT @ TCTAP 2017: Deep Dive Session on Left Main Intervention 2017 PCI vs. CABG in LM PCI - Where Are We in 2017? |
Lecturer |
April 26 | 7:00 AM - 8:10 AM | Room 105, Level 1 | Antithrombotic Therapy: Finding the ¡°Sweet-Spot¡± | Panelist |
April 26 | 7:30 AM - 7:45 AM | Room 105, Level 1 | Antithrombotic Therapy: Finding the ¡°Sweet-Spot¡± DAPT After BRS Implantation: The Longer the Better? |
Lecturer |
April 26 | 2:00 PM - 4:00 PM | Presentation Theater, Level 1 | Left Main and Bifurcation PCI: Prospects and Challenges | Panelist |
April 26 | 2:08 PM - 2:16 PM | Presentation Theater, Level 1 | Left Main and Bifurcation PCI: Prospects and Challenges A Multicenter Registry Evaluating New Generation Drug-Eluting Stents in Patients with Obstructive Left Main Coronary Artery Disease: DELTA II |
Lecturer |
April 26 | 4:00 PM - 4:08 PM | Presentation Theater, Level 1 | BRS & DES: Current Status, Future Perspectives, Data, Practical Tips and Tricks Updated BRS Data; Trials and Registries |
Lecturer |
April 26 | 4:00 PM - 6:00 PM | Presentation Theater, Level 1 | BRS & DES: Current Status, Future Perspectives, Data, Practical Tips and Tricks | Panelist |
April 27 | 7:00 AM - 8:10 AM | Presentation Theater, Level 1 | BRS and DES | Panelist |
April 27 | 7:08 AM - 7:16 AM | Presentation Theater, Level 1 | BRS and DES Is BRS Safe? |
Lecturer |
April 27 | 7:16 AM - 7:24 AM | Presentation Theater, Level 1 | BRS and DES BRS for Complex Lesions; Share the Experience |
Lecturer |
April 27 | 8:30 AM - 10:00 AM | Coronary Theater, Level 1 | Live Case & Lecture Session IV | Discussant |
April 27 | 11:06 AM - 12:18 PM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC | Discussant |
April 27 | 11:50 AM - 11:54 AM | Presentation Theater, Level 1 | Spotlights of New Clinical Trials & 2017 New Data from AMC Discussion: [TCTAP A-001] Thirty-day Clinical Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients Presenting with Acute Coronary Syndromes Versus Stable Coronary Artery Disease: Results from the Italian RAI Registry |
Discussant |